Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-16-013437
Filing Date
2016-05-16
Accepted
2016-05-16 16:02:20
Documents
91
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2015_amarantusbioscience.htm 10-K 1382867
2 LIST OF SUBSIDIARIES f10k2015ex21i_amarantusbio.htm EX-21.1 2201
3 CONSENT OF MARCUM LLP f10k2015ex23i_amarantusbio.htm EX-23.1 2585
4 CERTIFICATION f10k2015ex31i_amarantusbio.htm EX-31.1 9945
5 CERTIFICATION f10k2015ex31ii_amarantusbio.htm EX-31.2 10162
6 CERTIFICATION f10k2015ex32i_amarantusbio.htm EX-32.1 5110
7 CERTIFICATION f10k2015ex32ii_amarantusbio.htm EX-32.2 5096
  Complete submission text file 0001213900-16-013437.txt   8362872

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ambs-20151231.xml EX-101.INS 1567424
9 XBRL SCHEMA FILE ambs-20151231.xsd EX-101.SCH 108415
10 XBRL CALCULATION FILE ambs-20151231_cal.xml EX-101.CAL 66512
11 XBRL DEFINITION FILE ambs-20151231_def.xml EX-101.DEF 410043
12 XBRL LABEL FILE ambs-20151231_lab.xml EX-101.LAB 829087
13 XBRL PRESENTATION FILE ambs-20151231_pre.xml EX-101.PRE 557339
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55016 | Film No.: 161653571
SIC: 2834 Pharmaceutical Preparations